TANG CAPITAL MANAGEMENT LLC Diversified Active

CIK: 0001232621 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 15, 2019

Total Value ($000): $542,747 (100.0% shares, 0.0% debt)

Holdings (9)

— ODONATE THERAPEUTICS INC 53.3%

Value ($000) $289,332 Shares 13,086,038 Est. Cost $24.20 Unrealized —

HRTX HERON THERAPEUTICS INC 25.9%

Value ($000) $140,386 Shares 5,744,096 Est. Cost $14.10 Unrealized +85.7%

RCKT ROCKET PHARMACEUTICALS INC 9.6%

Value ($000) $52,015 Shares 2,965,485 Est. Cost $16.31 Unrealized -3.2%

— LA JOLLA PHARMACEUTICAL CO 5.9%

Value ($000) $31,757 Shares 4,938,893 Est. Cost $15.94 Unrealized —

PBYI PUMA BIOTECHNOLOGY INC 2.5%

Value ($000) $13,553 Shares 349,400 Est. Cost $30.17 Unrealized +1.2%

— CELGENE CORP 1.9%

Value ($000) $10,551 Shares 111,844 Est. Cost $94.34 Unrealized —

PRTA PROTHENA CORP PLC 0.7%

Value ($000) $3,928 Shares 323,823 Est. Cost $12.40 Unrealized +0.7%

— OPHTHOTECH CORP 0.2%

Value ($000) $846 Shares 600,000 Est. Cost $1.20 Unrealized —

EQ EQUILLIUM INC 0.1%

Value ($000) $379 Shares 47,343 Est. Cost $13.90 Unrealized -40.8%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ODONATE THERAPEUTICS INC	13,086,038	$289,332	53.3%	$24.20	—	COM	676079106
HRTX	HERON THERAPEUTICS INC	5,744,096	$140,386	25.9%	$14.10	+85.7%	COM	427746102
RCKT	ROCKET PHARMACEUTICALS INC	2,965,485	$52,015	9.6%	$16.31	-3.2%	COM	77313F106
—	LA JOLLA PHARMACEUTICAL CO	4,938,893	$31,757	5.9%	$15.94	—	COM	503459604
PBYI	PUMA BIOTECHNOLOGY INC	349,400	$13,553	2.5%	$30.17	+1.2%	COM	74587V107
—	CELGENE CORP	111,844	$10,551	1.9%	$94.34	—	COM	151020104
PRTA	PROTHENA CORP PLC	323,823	$3,928	0.7%	$12.40	+0.7%	SHS	G72800108
—	OPHTHOTECH CORP	600,000	$846	0.2%	$1.20	—	COM	683745103
EQ	EQUILLIUM INC	47,343	$379	0.1%	$13.90	-40.8%	COM	29446K106